Motivation issues for incorporating PDTs into insurance policies

Megan Cooder, PhD, MBA: Mr. Jeffrey, I might like to listen to your standpoint. Once we discuss virtual remedies, particularly virtual prescriptions [PDTs]There’s a gated mechanism in position, because it should be lined by means of a third-party person or entity and prescribed by means of a doctor. Out of your standpoint, how have you … Read more